The cumulative probability of sustained IOP elevation or of initiation or augmentation of ocular hypotensive therapy by @ years , after repeated ranibizumab injections , was @ % for the participants who received ranibizumab plus prompt or deferred focal/grid laser treatment vs @ % for the participants who received a sham injection plus focal/grid laser treatment ( difference , @ % -LSB- @ % CI , -@ % to @ % -RSB- ; hazard ratio , @ -LSB- @ % CI , @-@ @ -RSB- ; P = @ ) .